The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
LIO-1: Lucitanib + nivolumab in patients with advanced solid tumors—Updated phase 1b results and initial experience in phase 2 ovarian cancer cohort.
 
Erika P. Hamilton
Consulting or Advisory Role - Arvinas (Inst); AstraZeneca (Inst); Black Diamond Therapeutics (Inst); Boehringer Ingelheim (Inst); CytomX Therapeutics (Inst); Daiichi Sankyo (Inst); Dantari (Inst); Deciphera (Inst); Eisai (Inst); Genentech/Roche (Inst); H3 Biomedicine (Inst); Lilly (Inst); Merck (Inst); Mersana (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Seagen (Inst); Silverback Therapeutics (Inst)
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); Akeso Biopharma (Inst); Amgen (Inst); ArQule (Inst); Arvinas (Inst); AstraZeneca (Inst); Black Diamond Therapeutics (Inst); Boehringer Ingelheim (Inst); Clovis Oncology (Inst); Compugen (Inst); Curis (Inst); CytomX Therapeutics (Inst); Daiichi Sankyo (Inst); Dana Farber Cancer Hospital (Inst); Deciphera (Inst); eFFECTOR Therapeutics (Inst); EMD Serono (Inst); Fochon Pharmaceuticals (Inst); Fujifilm (Inst); G1 Therapeutics (Inst); Genentech/Roche (Inst); H3 Biomedicine (Inst); Harpoon (Inst); Hutchison MediPharma (Inst); Immunogen (Inst); Immunomedics (Inst); Infinity Pharmaceuticals (Inst); InventisBio (Inst); Karyopharm Therapeutics (Inst); Leap Therapeutics (Inst); Lilly (Inst); Lycera (Inst); Macrogenics (Inst); MedImmune (Inst); Merck (Inst); Mersana (Inst); Merus (Inst); Millennium (Inst); Molecular Templates (Inst); Novartis (Inst); Nucana (Inst); Olema Pharmaceuticals (Inst); OncoMed (Inst); Onconova Therapeutics (Inst); Orinove (Inst); Pfizer (Inst); PharmaMar (Inst); Plexxikon (Inst); Polyphor (Inst); Puma Biotechnology (Inst); Radius Health (Inst); Regeneron (Inst); Rgenix (Inst); Seagen (Inst); Sermonix Pharmaceuticals (Inst); Shattuck Labs (Inst); Silverback Therapeutics (Inst); Stem CentRx (Inst); Sutro Biopharma (Inst); Syndax (Inst); Syros Pharmaceuticals (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); TapImmune Inc. (Inst); Tesaro (Inst); Torque (Inst); Torque (Inst); Verastem (Inst); Zenith Epigenetics (Inst); Zymeworks (Inst)
 
Camille Catherine Jackson
Consulting or Advisory Role - Agenus; Clovis Oncology; Cordgenics; GlaxoSmithKline/Tesaro; Leap Therapeutics
Research Funding - Clovis Oncology; Genentech
 
Ramez Nassef Eskander
Consulting or Advisory Role - Agenus; AstraZeneca/MedImmune; Clovis Oncology; Daiichi Sankyo/Lilly; Eisai; Merck; Myriad Genetics; Pfizer; Tesaro
Speakers' Bureau - AstraZeneca/MedImmune; Myriad Genetics
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Eisai; Merck
 
Floor Jenniskens Backes
Consulting or Advisory Role - Abbott Diagnostics (I); Agenus; AstraZeneca; Clovis Oncology; CMR Institute; Eisai; Genentech; GlaxoSmithKline; Merck
Research Funding - Clovis Oncology (Inst); Eisai (Inst); Immunogen (Inst); Merck (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate (for writing a chapter)
 
Vicky Makker
Honoraria - Eisai; IBM; Karyopharm Therapeutics; Merck
Consulting or Advisory Role - ArQule; Clovis Oncology; Eisai; Faeth Therapeutics; GlaxoSmithKline; IBM; Karyopharm Therapeutics; Merck; Takeda
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Eisai (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Merck (Inst); Takeda (Inst); Zymeworks (Inst)
Travel, Accommodations, Expenses - Eisai; Karyopharm Therapeutics; Merck
Other Relationship - IBM
 
Fernanda Musa
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; GlaxoSmithKline/Tesaro; Seagen
 
Alexander Olawaiye
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Genentech; tesaro
 
Jill Alldredge
No Relationships to Disclose
 
Bhavana Pothuri
Consulting or Advisory Role - AstraZeneca; BioAscent; Clovis Oncology; Curio Science; Department of Defense; Eisai; Elevar Therapeutics; GlaxoSmithKline; Intuitive Surgical; McGivney Global Advisors; Merck; Mersana; Rubin, Paterniti, Gonzalez LLC; Tesaro; Toray Industries; Vaniam Group
Research Funding - AstraZeneca (Inst); Celgene (Inst); Celsion (Inst); Clovis Oncology (Inst); Genentech (Inst); Immunogen (Inst); Merck (Inst); Takeda (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; Eisai; Tesaro
 
Angeles Alvarez Secord
Honoraria - Aravive; Clovis Oncology; Eisai; Merck; Myriad Genetics; Tesaro/GSK
Consulting or Advisory Role - Aravive; Clovis Oncology; Eisai; Merck; Tesaro
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Clovis Oncology (Inst); Eisai (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Immutep (Inst); Merck (Inst); OncoQuest Pharmaceuticals (Inst); PharmaMar (Inst); Seagen (Inst); Tesaro (Inst); VBL Therapeutics (Inst)
(OPTIONAL) Uncompensated Relationships - GOG Foundation; OncoQuest Pharmaceuticals; Roche/Genentech; VBL Therapeutics
 
Nicole Concin
Consulting or Advisory Role - AstraZeneca; Mersana; Seagen
Travel, Accommodations, Expenses - Amgen; Genmab; Medscape; Roche
 
Antonio Gonzalez Martin
Consulting or Advisory Role - Amgen; AstraZeneca; Clovis Oncology; Genmab; Immunogen; MSD; Oncoinvent; Pfizer/EMD Serono; Roche; Tesaro/GSK
Speakers' Bureau - AstraZeneca; PharmaMar; Roche; Tesaro/GSK
Research Funding - Roche (Inst); Tesaro/GSK (Inst)
Travel, Accommodations, Expenses - AstraZeneca; PharmaMar; Roche; Tesaro/GSK
 
Jowell Go
Employment - Clovis Oncology
Stock and Other Ownership Interests - Clovis Oncology
 
Kenton Wride
Employment - Clovis Oncology
Stock and Other Ownership Interests - Clovis Oncology
 
Denise M. Lepley
Employment - Clovis Oncology
Stock and Other Ownership Interests - Clovis Oncology
 
Teresa Cameron
Employment - Clovis Oncology
Stock and Other Ownership Interests - Clovis Oncology
Patents, Royalties, Other Intellectual Property - Patent application submitted January 2020 for dosing methodology (Inst)
 
Manish R. Patel
Honoraria - Bayer; Genentech; Janssen Oncology; Pfizer; Pharmacyclics
Consulting or Advisory Role - Pfizer/EMD Serono; Pharmacyclics/Janssen
Speakers' Bureau - Celgene; Exelixis; Genentech/Roche; Taiho Pharmaceutical
Research Funding - Acerta Pharma (Inst); ADC Therapeutics (Inst); Agenus (Inst); Aileron Therapeutics (Inst); Artios (Inst); AstraZeneca (Inst); Bicycle Therapeutics (Inst); BioNTech (Inst); Boehringer Ingelheim (Inst); Calithera Biosciences (Inst); Celgene (Inst); Checkpoint Therapeutics (Inst); CicloMed (Inst); Clovis Oncology (Inst); Curis (Inst); cyteir (Inst); Daiichi Sankyo (Inst); eFFECTOR Therapeutics (Inst); EMD Serono (Inst); Erasca, Inc (Inst); Evelo Therapeutics (Inst); FORMA Therapeutics (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); H3 Biomedicine (Inst); Hengrui Therapeutics (Inst); Hutchison MediPharma (Inst); IgM Biosciences (Inst); Ignyta (Inst); Incyte (Inst); Jacobio (Inst); Janssen (Inst); Jounce Therapeutics (Inst); Klus Pharma (Inst); Kymab (Inst); Lilly (Inst); Loxo (Inst); LSK BioPharma (Inst); Lycera (Inst); MabSpace Biosciences (Inst); Macrogenics (Inst); Merck (Inst); Millennium (Inst); Mirati Therapeutics (Inst); Moderna Therapeutics (Inst); ORIC Pharmaceuticals (Inst); Pfizer (Inst); Phoenix Molecular Designs (Inst); Placon (Inst); Portola Pharmaceuticals (Inst); Prelude Therapeutics (Inst); PubGene (Inst); Puretech (Inst); QiLu Pharmaceutical (Inst); Revolution Medicines (Inst); Ribon Therapeutics (Inst); Seven and Eight Biopharmaceuticals (Inst); Stemline Therapeutics (Inst); Syndax (Inst); Synthorx (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Tesaro (Inst); TopAlliance BioSciences Inc (Inst); Treadwell Therapeutics (Inst); Vedanta Biosciences (Inst); Verastem (Inst); Vigeo Therapeutics (Inst); Xencor (Inst)